← Open Payments lookup

MOHAMMAD WAQAS: Open Payments

NPI 1033755921 · GALLOWAY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$567 in 38 payments from 12 companies in 2025. Trend: 2023 $407 · 2024 $764 · 2025 $567

Food & beverage: $567
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.17$194
Bayer Healthcare Pharmaceuticals Inc.4$70
Neurocrine BioSciences, Inc.3$58
AstraZeneca Pharmaceuticals LP3$52
Amgen Inc.2$36
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$35
Lundbeck LLC2$34
Boston Scientific Corporation1$22
Vanda Pharmaceuticals Inc.1$17
Neos Therapeutics, LP1$17

Products named: REXULTI, Kerendia, INGREZZA, REPATHA, CAPLYTA, AIRSUPRA, WATCHMAN Access System, FARXIGA.

Industry payments across NJ — which companies pay providers there.